非动脉炎性前部缺血性视神经病变中视网膜内和视网膜下液体的发生:发病机制、预后与治疗
这项回顾性单中心研究纳入2014至2021年间转诊至神经眼科部门的32例非动脉炎性前部缺血性视神经病变(NAAION)患者,描述视网膜内和视网膜下液体的频率与特征及其对视力缺损和视神经纤维/神经节细胞丢失的影响。21眼(46.7%)观察到视网膜液体,视觉功能在观察期内保持稳定。结论认为视网膜下液体在NAAION中占较高比例,皮质类固醇摄入未影响视觉恢复或组织水肿吸收时间,研究结果不支持对NAAION急性期使用皮质类固醇治疗。
要点
- 21眼(46.7%)观察到视网膜液体,其中19例为旁中心凹液体(9例同时有中心凹下液体)。
- 视觉 acuity、视野缺损和中心凹阈值在观察期内保持稳定(P=0.74、P=0.42、P=0.36)。
- 6个月时接受(n=10)与未接受(n=11)皮质类固醇治疗的患者视觉功能无差异(P=0.13、P=0.59、P=0.66)。
核心结论
- 视网膜下液体在NAAION中占较高比例,本队列视觉功能从初诊起基本保持稳定。
- 初诊时使用皮质类固醇未影响视觉恢复或组织水肿吸收的时间。
- 研究结果不支持对有或无视网膜下液体证据的NAAION急性期使用皮质类固醇治疗。
- 作者提出视盘处产生的漏出液体积是发病机制的关键因素,而非视网膜重吸收机制功能障碍。
研究设计与样本
- 回顾性、单中心研究,纳入2014至2021年间转诊至神经眼科部门的32例NAAION患者。
- 研究在比利时列日大学医院开展;对标准OCT发现视网膜下液体的参与者额外行黄斑OCT检查。
- 手动确定视网膜液体的模式和最大高度,并使用OCT协议分析获取视网膜各层厚度。
主要发现
- 队列平均年龄60岁(标准差±12.5;范围22-88岁),65.6%为男性。
- 21眼(46.7%)观察到视网膜液体:19例为旁中心凹液体(其中9例同时有中心凹下液体),1例仅有中心凹下液体,1例仅有视盘周围视网膜下液体。
- 特定的视盘肿胀模式与视网膜水肿的发生和分布相关。
- 视觉 acuity、视野缺损和中心凹阈值在观察期内保持稳定(分别为P=0.74、P=0.42、P=0.36)。
- 6个月时,接受(n=10)与未接受(n=11)皮质类固醇治疗的患者视觉功能无差异(视觉 acuity P=0.13;中心凹阈值 P=0.59;平均偏差 P=0.66)。
关键数值与推荐
- 21眼(46.7%)观察到视网膜液体,其中19例为旁中心凹液体(9例同时有中心凹下液体),1例仅有中心凹下液体,1例仅有视盘周围视网膜下液体。
- 视觉 acuity、视野缺损和中心凹阈值在观察期内保持稳定(P=0.74、P=0.42、P=0.36)。
- 6个月时接受与未接受皮质类固醇治疗的患者视觉功能无差异(视觉 acuity P=0.13;中心凹阈值 P=0.59;平均偏差 P=0.66)。
临床怎么用
- 研究结果不支持对有或无视网膜下液体证据的NAAION急性期使用皮质类固醇治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the frequency and characteristics of intraretinal and subretinal fluid in nonarteritic anterior ischemic optic neuropathy (NAAION) and to assess the influence on the visual deficit and optic nerve fiber/ganglion cell loss. DESIGN: A retrospective, single-center study. PARTICIPANTS: Thirty-two patients with NAAION referred to our Neuro-ophthalmology Department between 2014 and 2021. METHODS: The study was carried out at the University Hospital of Liège, Belgium. For participants in whom subretinal fluid was identified on standard OCT (Carl Zeiss Meditec) an additional macular OCT (Spectralis Heidelberg) had been performed. The pattern and the maximal height of the retinal fluid were determined manually, and thicknesses of retinal layers were obtained using the OCT protocol analysis. RESULTS: The mean age of the cohort was 60 years (standard deviation, ±12.5; range, 22-88 years), and 65.6% were male. In the 21 eyes (46.7%) in which retinal fluid was observed, macular OCT findings were categorized according to fluid localization: 19 cases had parafoveal fluid (of whom 9 also had subfoveal fluid). One patient had subfoveal fluid alone, and 1 patient had peripapillary subretinal fluid alone. Specific patterns of optic disc (OD) swelling were associated with the occurrence and distribution of retinal edema. Visual acuity, visual field loss, and foveal thresholds were stable over the period of observation (P = 0.74, P = 0.42, and P = 0.36, respectively). No difference was found in visual function at 6 months between patients with retinal fluid treated (n = 10) or not treated (n = 11) with corticosteroids (visual acuity, P = 0.13; foveal threshold, P = 0.59; mean deviation, P = 0.66). CONCLUSIONS: Subretinal fluid is found in a high proportion of cases of NAAION. Visual function remained largely stable from presentation in this cohort. Corticosteroid intake at presentation did not influence visual recovery or timing of the resorption of tissue edema. Our findings do not support treatment of NAAION with corticosteroids with or without evidence of subretinal fluid acutely. With regard to pathogenesis, we propose that the volume of transudate generated at the OD is the critical factor rather than dysfunction of retinal mechanisms subserving reabsorption. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
引用
- Chapelle AC, Rakic JM, Plant GT, et al. The Occurrence of Intraretinal and Subretinal Fluid in Anterior Ischemic Optic Neuropathy: Pathogenesis, Prognosis, and Treatment. Ophthalmology. 2023. PMID: 37479117. doi:10.1016/j.ophtha.2023.07.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。